Insys Therapeutics, Inc.
(NASDAQ : INSY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.71%89.281.3%$809.69m
AMGNAmgen Inc.
1.24%187.791.2%$636.76m
GILDGilead Sciences, Inc.
0.45%65.850.9%$484.50m
BIIBBiogen Inc.
1.12%324.761.3%$432.22m
ILMNIllumina, Inc.
1.36%300.923.5%$315.59m
REGNRegeneron Pharmaceuticals, Inc.
0.89%422.342.6%$292.76m
VRTXVertex Pharmaceuticals Incorporated
0.98%184.861.9%$256.08m
ALXNAlexion Pharmaceuticals, Inc.
1.33%129.242.0%$222.59m
SRPTSarepta Therapeutics, Inc.
1.88%139.1115.4%$155.20m
AAgilent Technologies, Inc.
0.10%77.971.6%$150.96m
EXASExact Sciences Corporation
8.98%90.7625.3%$144.16m
INCYIncyte Corporation
1.28%84.402.5%$113.37m
ARRYArray BioPharma Inc.
4.30%23.698.2%$112.67m
EXELExelixis, Inc.
0.71%21.376.4%$82.65m
NBIXNeurocrine Biosciences, Inc.
2.75%79.445.1%$79.35m

Company Profile

INSYS Therapeutics, Inc. is a c pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products. Its products include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary, orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ.